Breaking News Instant updates and real-time market news.

AXGN

AxoGen

$17.83

0.325 (1.86%)

07:14
07/26/19
07/26
07:14
07/26/19
07:14

AxoGen announces publication of 100th peer-reviewed clinical paper

Axogen announced publication of the 100th peer-reviewed paper featuring results from clinical studies involving its product portfolio. The latest paper, Inferior Alveolar Nerve: To Graft or Not to Graft in Ablative Mandibular Resection? by Maryam Akbari, DMD, MPH, MD, and Michael Miloro, DMD, MD was published in the Journal of Oral and Maxillofacial Surgery. The study explored factors that influence nerve repair in mandible reconstruction and offered techniques and treatment recommendations on how to incorporate nerve repair into the reconstruction. It joins a robust list of publications which represent a depth of clinical evidence from both sponsored and independent investigator studies that cover a range of nerve repair applications including extremity trauma, oral and maxillofacial reconstruction, breast reconstruction neurotization, and repair following the removal of painful neuromas. Research findings were shared over the past ten years in over 40 different peer-reviewed scientific journals and academic publications including The Journal of Hand Surgery, Journal of Oral Maxillofacial Surgery, Microsurgery, Regenerative Medicine, and Annals of Plastic Surgery. Studies of Avance Nerve Graft show positive outcomes while eliminating the donor site comorbidities associated with autograft. The library of 100 publications, spanning the use of Avance Nerve Graft and the Axoguard family of products, includes: Research from nearly 300 surgeon and clinical investigators; More than 90 independent non-sponsored papers, which highlights growing surgeon interest and acceptance of the Axogen portfolio of products; Repair of digital nerves in 37 publications and repair of mixed and motor nerves in 29 publications, with consistent results in short and long gap nerve injuries and sensory, mixed and motor nerve repairs; 18 publications in oral and maxillofacial reconstruction, a growing surgical application; and Six publications featuring data reports from the RANGER Study, with an 85% overall meaningful recovery rate across all nerve repairs in the study.

  • 06

    Aug

  • 14

    Aug

  • 09

    Sep

AXGN AxoGen
$17.83

0.325 (1.86%)

12/19/18
JMPS
12/19/18
NO CHANGE
JMPS
Outperform
JMP says short's suggestion of AxoGen saturation inconsistent with performance
After Seligman Investments distributed a "lengthy" short report on AxoGen that contributed to the stock declining by about 22% yesterday, JMP Securities analyst David Turkaly said he views the three most meaningful remarks as raising potential concerns over the company's previously stated addressable market size, portfolio of intellectual property and current market valuation. However, he believes AxoGen's sales growth, increased rep hiring, active account additions and guidance show that the market saturation suggested by the short report author is inconsistent with recent performance. The short also touched on the regulatory status of Avance, but Turkaly believes AxoGen has been taking adequate steps to successfully progress through its clinical pathway and "constructively communicate" with the FDA, the analyst added. He maintains an Outperform rating and $43 price target on AxoGen shares.
03/25/19
BTIG
03/25/19
UPGRADE
Target $28
BTIG
Buy
AxoGen upgraded to Buy from Neutral at BTIG
BTIG analyst Ryan Zimmerman upgraded AxoGen to Buy with a price target of $28, citing the stabilizing of its sales force based on his analysis of LinkedIn data and expectations that the management will have learned from its past mistakes by offering a more conservative guidance. The analyst also believes that AxoGen could become an M&A target since its potential acquirers have improved leverage ratios and have discussed deploying capital. Moreover, Zimmerman anticipates AxoGen's Avance nerve graft platform to be granted a Biologics License Application status by the FDA, but even in its absence, the analyst contends the company "isn't limited from selling Avance under 361 HCT/P," or Human cells, tissues, or cellular or tissue-based products regulations.
05/09/19
CANT
05/09/19
NO CHANGE
Target $30
CANT
Overweight
AxoGen price target raised to $30 from $26 at Cantor Fitzgerald
Cantor Fitzgerald analyst Craig Bijou raised his price target for AxoGen to $30 from $26 saying the company's Q1 growth was a "strong start to the year and a big first step to restore investor confidence." He reiterates an Overweight rating on the shares.
07/12/19
ADAM
07/12/19
INITIATION
Target $32
ADAM
Buy
AxoGen initiated with a Buy at Canaccord
Canaccord analyst Kyle Rose initiated AxoGen with a Buy rating and $32 price target. In a research note to investors, Rose says he believes the investments in the commercial team, market development initiatives and clinical trials position the company to reaccelerate growth into the second half of 2019. Rose says he feels the current valuation represents a compelling entry point, with top-line growth exceeding 30%, a strong balance sheet an an "exceptional" gross margin profile.

TODAY'S FREE FLY STORIES

WE

We Company

$0.00

(0.00%)

13:38
09/19/19
09/19
13:38
09/19/19
13:38
Periodicals
WeWork leaves sensitive documents exposed via 'weak' Wi-Fi, CNet reports »

WeWork's weak Wi-Fi…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ENS

EnerSys

$64.00

0.24 (0.38%)

13:34
09/19/19
09/19
13:34
09/19/19
13:34
Hot Stocks
EnerSys reports fire at Richmond, Kentucky production facility »

EnerSys reports that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 02

    Oct

  • 13

    Nov

  • 14

    Nov

EE

El Paso Electric

$66.83

0.13 (0.19%)

, JPM

JPMorgan

$120.02

0.25 (0.21%)

13:29
09/19/19
09/19
13:29
09/19/19
13:29
Hot Stocks
El Paso Electric investors approve deal to be acquired by IIF »

El Paso Electric Company…

EE

El Paso Electric

$66.83

0.13 (0.19%)

JPM

JPMorgan

$120.02

0.25 (0.21%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 15

    Oct

  • 27

    Oct

ADVM

Adverum Biotechnologies

$6.47

0.28 (4.52%)

13:25
09/19/19
09/19
13:25
09/19/19
13:25
Options
Adverum Biotechnologies call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Oct

13:25
09/19/19
09/19
13:25
09/19/19
13:25
General news
FX Action: USD-JPY »

FX Action: USD-JPY has…

TDOC

Teladoc

$69.70

2.22 (3.29%)

13:25
09/19/19
09/19
13:25
09/19/19
13:25
Conference/Events
Teladoc participates in a conference call with Citigroup »

Citigroup holds an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

FANG

Diamondback Energy

$97.34

-0.89 (-0.91%)

13:25
09/19/19
09/19
13:25
09/19/19
13:25
Conference/Events
Diamondback Energy participates in a conference call with JPMorgan »

Conference call with CEO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 02

    Oct

PEI

Pennsylvania REIT

$5.65

0.43 (8.24%)

13:23
09/19/19
09/19
13:23
09/19/19
13:23
Hot Stocks
Pennsylvania REIT jumps over 8% after insiders purchase shares »

Shares of Pennsylvania…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDR

McDermott

$1.66

-0.5 (-23.15%)

13:19
09/19/19
09/19
13:19
09/19/19
13:19
Periodicals
McDermott CEO cancels appearance after hiring adviser, Bloomberg reports »

McDermott International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

13:17
09/19/19
09/19
13:17
09/19/19
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

13:16
09/19/19
09/19
13:16
09/19/19
13:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PHUN

Phunware

$1.97

0.21 (11.93%)

13:10
09/19/19
09/19
13:10
09/19/19
13:10
Hot Stocks
Phunware jumps over 17% after saying it will launch IEO of Phun tokens »

Earlier on Thursday,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MACK

Merrimack

$5.58

0.22 (4.10%)

13:10
09/19/19
09/19
13:10
09/19/19
13:10
Hot Stocks
Newtyn Management discloses 8.8% stake in Merrimack Pharmaceuticals »

Noah Levy's Newtyn…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

13:10
09/19/19
09/19
13:10
09/19/19
13:10
General news
Treasury Action: the markets are likely to settle down, awaiting the next big thing »

Treasury Action: the…

MAR

Marriott

$130.22

0.07 (0.05%)

13:08
09/19/19
09/19
13:08
09/19/19
13:08
Hot Stocks
Marriott announces agreement to bring Ritz-Carlton brand to Montenegro »

Marriott International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:06
09/19/19
09/19
13:06
09/19/19
13:06
General news
10-Yr TIPS Auction Total Amount data reported »

10-Yr TIPS Auction Total…

13:06
09/19/19
09/19
13:06
09/19/19
13:06
General news
10-Yr TIPS Auction Coupon Rate data reported »

10-Yr TIPS Auction Coupon…

WBA

Walgreens Boots Alliance

$54.79

0.365 (0.67%)

, GOOGL

Alphabet Class A

$1,237.98

5.02 (0.41%)

13:06
09/19/19
09/19
13:06
09/19/19
13:06
Hot Stocks
Walgreens to test on-demand drone delivery service with Wing »

Walgreens (WBA) and Wing,…

WBA

Walgreens Boots Alliance

$54.79

0.365 (0.67%)

GOOGL

Alphabet Class A

$1,237.98

5.02 (0.41%)

GOOG

Alphabet

$1,238.09

5.46 (0.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 27

    Oct

GOOG

Alphabet

$1,238.27

5.64 (0.46%)

, GOOGL

Alphabet Class A

$1,238.02

5.06 (0.41%)

13:05
09/19/19
09/19
13:05
09/19/19
13:05
Hot Stocks
Wing partners with FedEx Express, Walgreens to launch drone delivery service »

Wing Aviation LLC, an…

GOOG

Alphabet

$1,238.27

5.64 (0.46%)

GOOGL

Alphabet Class A

$1,238.02

5.06 (0.41%)

FDX

FedEx

$150.71

-0.2 (-0.13%)

WBA

Walgreens Boots Alliance

$54.80

0.38 (0.70%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 24

    Sep

  • 30

    Sep

  • 01

    Oct

  • 27

    Oct

  • 13

    Nov

  • 17

    Dec

EROS

Eros International

$3.43

0.88 (34.51%)

13:04
09/19/19
09/19
13:04
09/19/19
13:04
Hot Stocks
Eros teams with Microsoft on 'next generation' online video platform »

Earlier today, Eros…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GSK

GlaxoSmithKline

$41.47

0.41 (1.00%)

13:04
09/19/19
09/19
13:04
09/19/19
13:04
Hot Stocks
GlaxoSmithKline granted orphan status for biliary cholangitis treatment »

The FDA granted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 27

    Sep

  • 02

    Oct

GRUB

GrubHub

$61.36

-2.42 (-3.79%)

12:55
09/19/19
09/19
12:55
09/19/19
12:55
Options
GrubHub put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:55
09/19/19
09/19
12:55
09/19/19
12:55
General news
FX Action: USD-CAD »

FX Action: USD-CAD has…

XGN

Exagen

$0.00

(0.00%)

12:54
09/19/19
09/19
12:54
09/19/19
12:54
Syndicate
Breaking Syndicate news story on Exagen »

Exagen opens at $16.80,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

XGN

Exagen

$0.00

(0.00%)

12:50
09/19/19
09/19
12:50
09/19/19
12:50
Syndicate
Breaking Syndicate news story on Exagen »

Exagen indicated to open…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.